Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

TSX:CHR-DB-B - Toronto Stock Exchange - CA17040TAE25 - Currency: CAD

100.16  0 (0%)

Fundamental Rating

4

Taking everything into account, CHR-DB-B scores 4 out of 10 in our fundamental rating. CHR-DB-B was compared to 9 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CHR-DB-B is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CHR-DB-B was profitable.
CHR-DB-B had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR-DB-B reported negative net income in multiple years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -16.53%, CHR-DB-B is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CHR-DB-B has a Return On Equity of -51.90%. This is in the lower half of the industry: CHR-DB-B underperforms 66.67% of its industry peers.
CHR-DB-B has a Return On Invested Capital of 6.82%. This is amongst the best in the industry. CHR-DB-B outperforms 88.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 6.12%.
The last Return On Invested Capital (6.82%) for CHR-DB-B is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -16.53%
ROE -51.9%
ROIC 6.82%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.78%, CHR-DB-B is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
CHR-DB-B has a better Gross Margin (64.61%) than 88.89% of its industry peers.
CHR-DB-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 64.61%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

CHR-DB-B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CHR-DB-B has less shares outstanding
The number of shares outstanding for CHR-DB-B has been reduced compared to 5 years ago.
The debt/assets ratio for CHR-DB-B has been reduced compared to a year ago.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR-DB-B has an Altman-Z score of 1.79. This is a bad value and indicates that CHR-DB-B is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CHR-DB-B (1.79) is better than 66.67% of its industry peers.
The Debt to FCF ratio of CHR-DB-B is 2.43, which is a good value as it means it would take CHR-DB-B, 2.43 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.43, CHR-DB-B belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B has a better Debt to Equity ratio (0.55) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.43
Altman-Z 1.79
ROIC/WACC0.88
WACC7.72%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR-DB-B has a Current Ratio of 0.95. This is a bad value and indicates that CHR-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.95, CHR-DB-B is in line with its industry, outperforming 55.56% of the companies in the same industry.
CHR-DB-B has a Quick Ratio of 0.95. This is a bad value and indicates that CHR-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHR-DB-B (0.69) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.69
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

CHR-DB-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 263.33%, which is quite impressive.
Measured over the past years, CHR-DB-B shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.95% on average per year.
The Revenue for CHR-DB-B has decreased by -16.43% in the past year. This is quite bad
Measured over the past years, CHR-DB-B shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)263.33%
EPS 3Y43.35%
EPS 5Y11.95%
EPS Q2Q%1100%
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%

3.2 Future

The Earnings Per Share is expected to grow by 15.78% on average over the next years. This is quite good.
CHR-DB-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.79% yearly.
EPS Next Y106.63%
EPS Next 2Y30.22%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-1.93%
Revenue Next 3Y1.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 91.89, which means the current valuation is very expensive for CHR-DB-B.
CHR-DB-B's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (28.92), we can say CHR-DB-B is valued expensively.
Based on the Price/Forward Earnings ratio of 44.47, the valuation of CHR-DB-B can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR-DB-B is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.65. CHR-DB-B is valued rather expensively when compared to this.
Industry RankSector Rank
PE 91.89
Fwd PE 44.47
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
CHR-DB-B's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR-DB-B is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.52
EV/EBITDA 13.94
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHR-DB-B's earnings are expected to grow with 15.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)7.69
EPS Next 2Y30.22%
EPS Next 3Y15.78%

More info and screens

0

5. Dividend

5.1 Amount

CHR-DB-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHORUS AVIATION INC

TSX:CHR-DB-B (4/16/2025, 7:00:00 PM)

100.16

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners1.95%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap2.66B
Analysts78.18
Price Target133.9 (33.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-10.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.73%
Min EPS beat(2)25.51%
Max EPS beat(2)207.96%
EPS beat(4)3
Avg EPS beat(4)41.76%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)3
Avg EPS beat(8)6.63%
EPS beat(12)4
Avg EPS beat(12)0%
EPS beat(16)7
Avg EPS beat(16)1.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.87%
Min Revenue beat(2)-7.96%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)-4.04%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)5.86%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)0.32%
Revenue beat(16)9
Avg Revenue beat(16)5.8%
PT rev (1m)-3.99%
PT rev (3m)0.01%
EPS NQ rev (1m)-3.66%
EPS NQ rev (3m)676.19%
EPS NY rev (1m)4.69%
EPS NY rev (3m)636.31%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 91.89
Fwd PE 44.47
P/S 1.89
P/FCF 12.52
P/OCF 10.02
P/B 5.19
P/tB 5.28
EV/EBITDA 13.94
EPS(TTM)1.09
EY1.09%
EPS(NY)2.25
Fwd EY2.25%
FCF(TTM)8
FCFY7.99%
OCF(TTM)9.99
OCFY9.98%
SpS52.98
BVpS19.3
TBVpS18.97
PEG (NY)0.86
PEG (5Y)7.69
Profitability
Industry RankSector Rank
ROA -16.53%
ROE -51.9%
ROCE 9.2%
ROIC 6.82%
ROICexc 8.69%
ROICexgc 8.78%
OM 6.78%
PM (TTM) N/A
GM 64.61%
FCFM 15.1%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.43
Debt/EBITDA 1.34
Cap/Depr 45.44%
Cap/Sales 3.76%
Interest Coverage 1.21
Cash Conversion 125.19%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.69
Altman-Z 1.79
F-Score6
WACC7.72%
ROIC/WACC0.88
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)263.33%
EPS 3Y43.35%
EPS 5Y11.95%
EPS Q2Q%1100%
EPS Next Y106.63%
EPS Next 2Y30.22%
EPS Next 3Y15.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-16.21%
Revenue Next Year-2.29%
Revenue Next 2Y-1.93%
Revenue Next 3Y1.79%
Revenue Next 5YN/A
EBIT growth 1Y-63.67%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year78.26%
EBIT Next 3Y15.88%
EBIT Next 5YN/A
FCF growth 1Y-17.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-11.57%
OCF growth 3Y12.73%
OCF growth 5Y0.25%